本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

Crescent Biopharma Inc

15.89
+0.34502.22%
盘后15.890.00000.00%16:57 EDT
成交量:17.11万
成交额:270.92万
市值:2.21亿
市盈率:-0.35
高:16.98
开:15.86
低:15.36
收:15.55
数据加载中...
2022/05/23

重要事件披露

8-K - Current report
2022/05/10

超过5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2022/05/09

重要事件披露

8-K - Current report
2022/05/09

季度报告

10-Q - Quarterly report [Sections 13 or 15(d)]
2022/05/02

超过5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2022/05/02

[修订]年度报告

10-K/A [Amend] - Annual report [Section 13 and 15(d), not S-K Item 405]
2022/04/21

超过5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2022/04/05

重要事件披露

8-K - Current report
2022/03/31

年度报告

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2022/03/31

员工持股计划

S-8 - Securities to be offered to employees in employee benefit plans
2022/03/16

重要事件披露

8-K - Current report
2022/03/16

超过5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2022/03/07

超过5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2022/03/04

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2022/02/28

超过5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2022/02/23

超过5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2022/02/18

重要事件披露

8-K - Current report
2022/02/14

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2022/02/14

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2022/02/14

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals